Launching Global Lung Function Initiative reference values in Belgium: tips and tricks
- PMID: 30072542
- DOI: 10.1183/13993003.00922-2018
Launching Global Lung Function Initiative reference values in Belgium: tips and tricks
Conflict of interest statement
Conflict of interest: E. Derom has nothing to disclose concerning the submitted manuscript, but received financial support from AstraZeneca, Chiesi and Boehringer Ingeheim to attend ERS and ATS congresses, and participated in national advisory boards for AstraZeneca, Boehringer, GSK, Novartis and Chiesi. Conflict of interest: W. Janssens reports receiving grants from GSK, AstraZeneca, Boehringer and Chiesi, outside the submitted work.
Comment in
-
The impact of the new Global Lung Function Initiative T LCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis.Eur Respir J. 2019 Jan 31;53(2):1801895. doi: 10.1183/13993003.01895-2018. Print 2019 Feb. Eur Respir J. 2019. PMID: 30760543 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources